Literature DB >> 7827620

Evidence for multiple forms of melatonin receptor-G-protein complexes by solubilization and gel electrophoresis.

P Barrett1, A MacLean, P J Morgan.   

Abstract

The daily production of melatonin from the pineal gland influences circadian and seasonal behaviour and physiology. To further understand how melatonin may function, it is important to characterize the receptor and signal transduction systems. Using the detergent digitonin, we were able to solubilize the receptor from the ovine pars tuberalis (PT) membrane. The receptor was isolated as a complex associated with its heterotrimeric G-protein. In the solubilized state, pre-bound 125I-2-iodomelatonin was stable at 4 degrees C, but was displaceable by GTP gamma S. The receptor-G-protein complex could be separated by molecular mass using native polyacrylamide gel electrophoresis. We demonstrate that the receptor-complex has a molecular mass of 525 kDa and differs from solubilized receptor-complexes isolated from either the lizard brain, chicken brain or the ovine hippocampus. Furthermore the receptor complex isolated from the hippocampus had the lowest molecular mass of these tissues (365 kDa) and was found not to be sensitive to GTP gamma S. This may indicate the existence of a distinct non-G-protein coupled form of the receptor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7827620     DOI: 10.1111/j.1365-2826.1994.tb00613.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  5 in total

1.  Molecular identification of the long isoform of the human neuropeptide Y Y5 receptor and pharmacological comparison with the short Y5 receptor isoform.

Authors:  Marianne Rodriguez; Valérie Audinot; Sandra Dromaint; Christelle Macia; Véronique Lamamy; Philippe Beauverger; Hervé Rique; Jérôme Imbert; Jean Paul Nicolas; Jean A Boutin; Jean Pierre Galizzi
Journal:  Biochem J       Date:  2003-02-01       Impact factor: 3.857

2.  The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization.

Authors:  Angélique Levoye; Julie Dam; Mohammed A Ayoub; Jean-Luc Guillaume; Cyril Couturier; Philippe Delagrange; Ralf Jockers
Journal:  EMBO J       Date:  2006-06-15       Impact factor: 11.598

3.  A generic approach for the purification of signaling complexes that specifically interact with the carboxyl-terminal domain of G protein-coupled receptors.

Authors:  Pascal Maurice; Avais M Daulat; Cédric Broussard; Julien Mozo; Guilhem Clary; Françoise Hotellier; Philippe Chafey; Jean-Luc Guillaume; Gilles Ferry; Jean A Boutin; Philippe Delagrange; Luc Camoin; Ralf Jockers
Journal:  Mol Cell Proteomics       Date:  2008-04-29       Impact factor: 5.911

4.  Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists.

Authors:  R Nonno; M Pannacci; V Lucini; D Angeloni; F Fraschini; B M Stankov
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 5.  Understanding melatonin receptor pharmacology: latest insights from mouse models, and their relevance to human disease.

Authors:  Gianluca Tosini; Sharon Owino; Jean-Luc Guillaume; Ralf Jockers
Journal:  Bioessays       Date:  2014-06-05       Impact factor: 4.345

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.